Agilon Health Investors Face March 2 Deadline in Securities Class Action Over 2025 Guidance

Overview

• Rosen Law Firm and the Law Offices of Howard G. Smith issued reminders, and Faruqi & Faruqi reiterated outreach on February 7, about the March 2, 2026 deadline to seek lead-plaintiff status.
• The filed complaints target purchasers of agilon health securities between February 26, 2025 and August 4, 2025.
• Plaintiffs allege executives issued 2025 guidance they knew or should have known was unattainable given industry headwinds.
• The suit also claims the company overstated the immediate financial benefits of risk‑reduction 'strategic actions,' rendering public statements misleading.
• agilon suspended its 2025 guidance on August 4, 2025, and the stock fell about 51% on August 5; no class has been certified and investors are not represented unless they retain counsel.